Page last updated: 2024-08-26

aucubin and Lung Neoplasms

aucubin has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, DD; Ou, JS; Ou, ZJ1
Huang, HW; Huang, MS; Hung, JY; Tsai, YM; Yang, CJ1

Other Studies

2 other study(ies) available for aucubin and Lung Neoplasms

ArticleYear
A potential agent for treating non-small cell lung cancer.
    Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:9

    Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation, Preclinical; Glucosides; Humans; Iridoid Glucosides; Iridoids; Lung Neoplasms; Phytotherapy; Plant Extracts; Rats; Treatment Outcome; Tumor Cells, Cultured

2008
Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells.
    Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:9

    Topics: Antibodies; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Genes, p53; Glucosides; Humans; Iridoid Glucosides; Iridoids; Lung Neoplasms

2008